We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Byondis’ Investigational Antibody-Drug Conjugate Selected for Trial in Early-Stage Breast Cancer

Product News   Jul 07, 2020

 
Byondis’ Investigational Antibody-Drug Conjugate Selected for Trial in Early-Stage Breast Cancer
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Eppendorf Introduces Multipurpose Centrifuge 5910 Ri To Accelerate Results

Product News

Eppendorf has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri.

READ MORE

Linkam FDCS196 Stage Used To Develop a Novel Transdermal Delivery System for Risperidone

Product News

A recent study describes for the first time the formation of room temperature therapeutic deep eutectic solvent (THEDES) of RIS, an antipsychotic drug that is used in the treatment of schizophrenia, mixed and manic states associated with bipolar disorder and irritability in children and adolescents with autism.

READ MORE

AnteoTech Secures CE Certification for Its Versatile EuGeni Rapid Diagnostic Platform

Product News

AnteoTech has announced that its EuGeni™ Reader and accompanying COVID-19 Antigen Rapid Test (ART) have received Conformité Européene (CE) Mark registration as the company looks to progress with European distribution.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE